"Roll the dice and it's a toss‐up between quality of life and life”: a mixed methods study exploring adherence to adjuvant endocrine therapy and interventions to improve adherence by Brett, Jo et al.
Roll the dice and it's a toss‐up between quality of life and life”: a mixed methods 
study exploring adherence to adjuvant endocrine therapy and interventions to 
improve adherence 
 
Dr. Jo Brett1* | Dr Debbie Fenlon2 | Dr Mary Boulton1 | 
Dr Nick Hulbert‐Williams3 | Dr Fiona Walter4 | 
Dr Peter Donnelly5 | Dr Nicola Stoner6 | Dr Adrienne Morgan7 | 
Mrs Carolyn Morris7 
 
1 Oxford Brookes University, Oxford, United Kingdom; 2 University of 
Southampton, Southampton, United Kingdom; 3 University of Chester, 
Chester, United Kingdom; 4 University of Cambridge, Cambridge, United 
Kingdom; 5 South Devon Healthcare NHS Foundation Trust, Torbay, 
United Kingdom; 6 Oxford University Hospitals Foundation NHS Trust, 
Oxford, United Kingdom; 7 Independent Cancer Patient Voice, London, 
United Kingdom 
 
Background: Despite the known efficacy of adjuvant endocrine 
therapy (AET) in reducing breast cancer recurrence and mortality, 
adherence is sub‐optimal. The aim of this study was to explore factors 
affecting adherence and non‐adherence to AET to inform interventions 
to support women with long‐term adherence. 
 
Methods: This mixed methods study includes a questionnaire survey 
(n = 211, 73%) and semi‐structured interviews (n = 32) with women 
prescribed AET who were at 2–4 years post treatment. Data were 
analysed in SPSS. The Framework approach was used to analyse 
transcripts, informed by the WHO Model of adherence and Beliefs 
about Medicine Model (Horne, 1999). 
 
Results: The questionnaire analysis found that factors significantly 
associated with intentional non‐adherences were the presence of side 
effects, concerns about AET, and lower perceived necessity to take 
AET. Factors significantly associated with unintentional non‐adherence 
were younger age, post‐secondary education, and being in paid 
employment. Interviews added depth to these findings. Non‐adherence 
was influenced by an unmanaged side effect profile, the desire 
for quality of life in remaining years in older women, a lack of belief 
in efficacy of AET, and ongoing concerns about the toxicity of AET. 
Adherence was influenced by limited impact of side effect profile on 
daily life, trust in health professionals, feeling supported in ongoing 
AET therapy, and belief in efficacy of AET. 
 
Conclusion: Reasons for adherence or non‐adherence to AET are variable and 
complex. Interventions are required to ensure women are 
well‐informed and supported to continue with AET where appropriate, 
thereby reducing breast cancer‐related morbidity and mortality 
